object
examin
pulmonari
function
exercis
capac
healthrel
qualiti
life
hrqol
among
sever
acut
respiratori
syndrom
sar
survivor
method
evalu
survivor
confirm
sar
princ
wale
hospit
hong
kong
month
symptom
onset
assess
includ
lung
volum
total
lung
capac
tlc
vital
capac
residu
volum
function
residu
capac
spirometri
fvc
fev
diffus
capac
lung
carbon
monoxid
dlco
inspiratori
expiratori
respiratori
muscl
strength
walk
distanc
chest
radiograph
cxr
hrqol
medic
outcom
studi
shortform
gener
health
survey
questionnair
result
ninetyseven
patient
complet
serial
assess
male
femal
patient
patient
healthcar
worker
mean
age
year
sd
year
bodi
mass
index
kgm
sd
kgm
year
patient
abnorm
cxr
find
four
patient
patient
patient
fvc
tlc
dlco
valu
predict
valu
respect
month
sd
higher
month
mean
differ
confid
interv
ci
p
differ
month
mean
differ
ci
p
lower
normal
control
subject
age
group
impair
hrqol
month
patient
requir
icu
admiss
n
show
higher
cxr
score
sd
vs
sd
p
lower
percentag
predict
fvc
tlc
dlco
differ
health
statu
conclus
signific
impair
dlco
note
survivor
year
ill
onset
exercis
capac
health
statu
sar
survivor
remark
lower
normal
popul
chest
key
word
sever
acut
respiratori
syndrom
lung
function
function
capac
qualiti
life
abbrevi
anova
analysi
varianc
bmi
bodi
mass
index
boop
bronchiol
obliteran
organ
pneumonia
bp
bodili
pain
ci
confid
interv
cpet
cardiopulmonari
exercis
test
crp
creactiv
protein
cxr
chest
radiograph
dlco
diffus
capac
lung
carbon
dioxid
fef
forc
expiratori
flow
midexpiratori
phase
frc
function
residu
capac
gh
gener
health
hcw
healthcar
worker
hk
hong
kong
hrct
highresolut
ct
hrqol
healthrel
qualiti
life
iqr
interquartil
rang
kco
diffus
capac
lung
carbon
dioxid
adjust
alveolar
volum
ldh
lactat
dehydrogenas
lo
length
stay
mh
mental
health
pemax
maximum
static
expiratori
pressur
pimax
maximum
static
inspiratori
pressur
pf
physic
function
role
limit
due
emot
problem
rp
role
limit
due
physic
problem
rv
residu
volum
sar
sever
acut
respiratori
syndrom
sf
social
function
medic
outcom
studi
shortform
gener
health
survey
tlc
total
lung
capac
va
alveolar
volum
vc
vital
capac
vt
vital
walk
distanc
walk
test
emerg
sever
acut
respiratori
syndrom
sar
southern
china
novemb
follow
global
outbreak
caught
medic
profess
surpris
studi
sarscoronaviru
viral
load
shown
peak
viral
level
reach
second
week
ill
patient
receiv
hospit
care
thu
healthcar
worker
hcw
particularli
prone
infect
care
patient
morbid
sar
highlight
observ
even
total
lung
field
involv
consolid
patient
would
requir
supplement
oxygen
order
maintain
oxygen
satur
sever
studi
shown
patient
requir
icu
admiss
wherea
progress
ard
necessit
invas
ventilatori
support
major
outbreak
sar
hospit
half
sar
infect
previous
healthi
hcw
highresolut
ct
hrct
perform
week
hospit
discharg
select
outpati
residu
opac
reveal
multipl
patchi
groundglass
appear
interstiti
thicken
patient
ct
evid
fibrot
chang
patient
like
ongo
activ
alveol
probabl
result
uncontrol
host
immun
respons
trigger
viral
antigen
may
lead
pulmonari
fibrosi
patient
previou
studi
survivor
acut
lung
injuri
ard
unrel
sar
shown
variabl
degre
residu
abnorm
pulmonari
function
exercis
capac
impair
healthrel
qualiti
life
hrqol
recent
report
sar
survivor
n
abnorm
diffus
capac
lung
carbon
monoxid
dlco
month
wherea
overal
exercis
capac
health
statu
lower
normal
popul
age
group
report
herein
outcom
prospect
followup
studi
sar
patient
cohort
epidemiolog
link
singl
index
case
major
hospit
outbreak
examin
serial
lung
function
exercis
capac
chest
radiograph
cxr
hrqol
month
onset
ill
addit
compar
sar
survivor
requir
icu
admiss
treat
medic
ward
refer
outcom
paramet
prospect
longitudin
followup
studi
patient
sar
discharg
hospit
surviv
major
outbreak
patient
came
previous
report
cohort
recruit
period
week
march
march
diagnosi
sar
base
center
diseas
control
prevent
criteria
time
patient
studi
subsequ
laboratori
confirm
sar
treatment
outcom
patient
hospit
report
detail
elsewher
prospect
outcom
studi
sar
survivor
approv
ethic
committe
chines
univers
hong
kong
follow
discharg
hospit
patient
evalu
lung
function
laboratori
end
month
diseas
onset
visit
subject
interview
underw
physic
examin
pulmonari
function
test
respiratori
muscl
strength
measur
posteroanterior
cxr
rest
oximetri
standard
walk
test
addit
complet
medic
outcom
studi
shortform
gener
health
survey
measur
hrqol
provid
standard
object
integr
assess
cardiopulmonari
musculoskelet
function
relev
daili
activ
selfpac
assess
submaxim
level
function
capac
appli
longterm
followup
studi
survivor
ard
walk
distanc
compar
norm
refer
data
collect
popul
survey
normal
healthi
subject
coordin
committe
physiotherapi
hong
kong
hospit
author
separ
day
control
subject
n
day
day
assess
sd
sd
respect
intraclass
correl
coeffici
confid
interv
ci
se
measur
minimum
detect
chang
limit
agreement
ci
data
stratifi
differ
age
group
avail
comparison
sar
patient
although
access
individu
data
popul
survey
includ
eight
multipleitem
domain
assess
physic
function
pf
social
function
sf
role
limit
due
physic
problem
rp
role
limit
due
emot
problem
mental
health
mh
bodili
pain
bp
vital
vt
gener
health
gh
score
aspect
rang
worst
best
higher
score
indic
better
hrqol
valid
chines
hong
kong
hk
version
appli
studi
result
compar
hk
norm
data
collect
random
telephon
survey
surfac
area
ga
exchang
dlco
adjust
hemoglobin
dlco
adjust
alveolar
volum
kco
perform
vmax
system
sensormed
yorba
linda
ca
dlco
determin
singlebreath
techniqu
use
infrar
analyz
perform
spirometri
fev
fvc
accord
standard
american
thorac
societi
result
compar
norm
data
wide
adopt
refer
data
hk
measur
maximum
static
inspiratori
pressur
pimax
subject
gener
mouth
maximum
static
expiratori
pressur
pemax
simpl
way
gaug
inspiratori
expiratori
muscl
strength
sinc
respiratori
muscl
weak
may
lead
restrict
pattern
lung
function
test
pimax
pemax
assess
mouth
pressur
meter
via
flang
mouthpiec
full
lung
function
test
studi
normal
subject
chines
indian
mean
age
year
singapor
maxim
static
inspiratori
effort
rv
group
cm
h
sd
cm
h
pimax
cm
h
pemax
cm
h
gener
exclud
clinic
signific
weak
inspiratori
expiratori
muscl
respect
radiograph
assess
frontal
cxr
perform
month
use
standard
techniqu
comput
radiographi
equip
report
major
hospit
outbreak
imag
assess
use
pictur
archiv
commun
system
magicview
siemen
erlangen
germani
viewer
model
siemen
lung
divid
three
zone
upper
middl
lower
frontal
radiographi
observ
assess
presenc
appear
airspac
opac
reticular
opac
distribut
size
lung
parenchym
abnorm
cxr
patient
size
lesion
assess
visual
estim
percentag
area
occupi
zone
side
overal
percentag
involv
obtain
averag
percentag
involv
six
lung
zone
frontal
cxr
closest
date
lung
function
test
assess
two
radiologist
blind
clinic
inform
find
reach
consensu
assess
method
describ
previou
studi
statist
analysi
perform
use
statist
softwar
statist
packag
social
scienc
version
spss
chicago
il
cumul
steroid
dosag
inpati
treatment
outpati
followup
convert
hydrocortison
milligram
facilit
analysi
studi
continu
variabl
compar
use
independentsampl
test
wherea
mannwhitney
u
test
use
nonparametr
data
categor
variabl
compar
use
test
statist
test
two
tail
statist
signific
taken
p
univari
analys
perform
evalu
potenti
determin
exercis
capac
express
variabl
signific
univari
analysi
p
includ
multivari
analysi
age
sex
control
analysi
final
multivari
model
independ
determin
repeatedmeasur
analysi
varianc
anova
use
assess
serial
chang
distanc
cxr
score
first
patient
sar
infect
march
patient
die
among
survivor
patient
attend
followup
month
month
wherea
anoth
patient
default
assess
default
month
patient
normal
lung
function
index
wherea
patient
dlco
predict
normal
valu
respect
month
thu
patient
complet
three
assess
among
patient
hcw
doctor
nurs
ward
assist
medic
student
patient
women
mean
age
year
sd
year
bodi
mass
index
bmi
kgm
sd
kgm
visit
month
ill
onset
hospit
length
stay
lo
group
day
sd
day
three
smoker
among
whole
group
patient
medic
comorbid
includ
copd
n
ischem
heart
diseas
n
ischem
stroke
n
breast
cancer
patient
stabl
clinic
condit
receiv
tamoxifen
n
diabet
mellitu
n
cirrhosi
n
hypertens
n
asymptomat
hepat
b
carrier
n
among
patient
patient
men
women
requir
icu
admiss
icu
lo
day
sd
day
median
day
rang
day
wherea
patient
requir
invas
mechan
ventil
base
icu
admiss
criteria
patient
would
pao
fraction
inspir
oxygen
ratio
mm
hg
wherea
patient
intub
pao
fraction
inspir
oxygen
ratio
mm
hg
among
patient
patient
medic
comorbid
includ
ischem
heart
diseas
n
diabet
mellitu
n
hypertens
n
asymptomat
hepat
b
carrier
n
none
histori
smoke
pulmonari
diseas
overview
serial
lung
function
test
respiratori
muscl
strength
result
group
shown
tabl
overal
lung
volum
paramet
surfac
area
exchang
well
preserv
month
signific
reduct
dlco
fef
alveolar
volum
va
wherea
increas
kco
studi
period
month
pimax
pemax
valu
cm
h
note
patient
patient
respect
month
frequenc
sar
survivor
lung
function
paramet
predict
valu
follow
month
fev
n
fvc
n
vc
n
tlc
n
dlco
n
kco
n
month
fev
n
fvc
n
vc
n
tlc
n
dlco
n
kco
n
month
fev
n
fvc
n
vc
n
tlc
n
dlco
n
kco
n
thu
patient
impair
dlco
wherea
patient
reduct
paramet
lung
volum
month
mean
increas
significantli
sd
month
sd
sd
month
month
respect
p
valu
trend
subject
stratifi
differ
age
group
compar
correspond
norm
valu
exercis
capac
gener
significantli
lower
normal
subject
tabl
sar
survivor
month
comparison
norm
data
shown
tabl
univari
follow
multivari
analys
control
age
gender
perform
look
factor
associ
tabl
month
independ
predictor
identifi
wherea
percentag
predict
fvc
posit
independ
predictor
month
month
independ
posit
predictor
percentag
predict
fvc
percentag
predict
dlco
thirtyseven
patient
note
abnorm
total
cxr
score
month
involv
sd
rang
total
lung
field
wherea
patient
abnorm
cxr
score
involv
sd
rang
lung
field
month
year
patient
abnorm
cxr
find
involv
sd
rang
lung
field
repeatedmeasur
anova
analysi
patient
abnorm
cxr
score
n
signific
trend
improv
month
p
correl
extent
cxr
abnorm
vs
cumul
steroid
dosag
lung
function
paramet
month
examin
signific
posit
correl
extent
radiograph
abnorm
percentag
lung
field
cumul
hydrocortison
dosag
r
p
signific
neg
correl
extent
percentag
radiograph
abnorm
tlc
r
p
dlco
r
p
howev
signific
correl
note
extent
radiograph
abnorm
vs
r
p
fev
r
p
rv
r
data
present
mean
sd
comparison
month
month
mean
differ
fef
ci
p
wherea
mean
differ
ci
p
comparison
month
month
p
valu
linear
trend
comparison
month
month
mean
differ
dlco
ci
p
wherea
mean
differ
ci
p
comparison
month
month
p
valu
linear
trend
comparison
month
month
mean
differ
kco
ci
p
wherea
mean
differ
ci
p
comparison
month
month
p
valu
linear
trend
signific
decreas
va
month
mean
differ
ci
p
month
mean
differ
ci
p
valu
linear
trend
patient
requir
icu
admiss
n
men
women
higher
peak
lactat
dehydrogenas
ldh
level
higher
peak
creactiv
protein
crp
level
longer
hospit
lo
receiv
significantli
higher
total
steroid
dose
requir
icu
care
tabl
lung
function
test
month
show
significantli
lower
percentag
predict
fvc
vc
tlc
rv
dlco
survivor
requir
icu
support
treat
medic
ward
although
signific
differ
note
respiratori
muscl
strength
two
group
tabl
domain
score
month
ill
onset
patient
requir
icu
support
acut
ill
comparison
norm
data
shown
figur
data
avail
onlin
supplement
tabl
signific
impair
health
statu
among
sar
survivor
month
compar
control
subject
age
group
directli
compar
requir
icu
admiss
treat
medic
ward
signific
differ
domain
two
group
month
compar
patient
requir
intub
icu
requir
intub
n
latter
sever
lung
injuri
reflect
higher
peak
addit
signific
differ
two
group
regard
lung
function
index
domain
score
month
data
avail
onlin
supplement
tabl
prospect
cohort
studi
shown
sar
survivor
impair
dlco
abnorm
cxr
find
respect
year
ill
onset
overal
serial
assess
show
signific
improv
month
exercis
capac
health
statu
still
significantli
lower
normal
control
subject
age
group
lung
function
index
percentag
predict
fvc
vc
tlc
rv
dlco
survivor
requir
icu
support
remark
lower
patient
treat
medic
ward
although
signific
differ
note
respiratori
muscl
strength
health
statu
two
group
interestingli
differ
lung
function
index
exercis
capac
health
statu
year
icuintub
icunonintub
sar
patient
although
former
sever
lung
injuri
base
hrct
appear
bronchiol
obliteran
organ
pneumonia
boop
clinic
suspicion
progress
pulmonari
diseas
might
mediat
host
inflammatori
respons
puls
methylprednisolon
administ
clinic
progress
sar
favor
respons
lung
histopatholog
condit
fatal
sar
case
domin
diffus
alveolar
damag
extens
consolid
featur
boop
inde
note
month
admiss
hospit
residu
abnorm
pulmonari
function
observ
three
fourth
queen
elizabeth
hospit
cohort
hk
n
mostli
consist
isol
reduct
dlco
wherea
abnorm
hrct
score
detect
patient
contrast
sar
survivor
impair
dlco
month
wherea
hrct
perform
patient
reveal
groundglass
opacif
reticul
patient
patient
respect
year
patient
signific
impair
dlco
wellpreserv
kco
serial
result
suggest
increas
intraalveolar
diffus
pathway
might
result
diffus
alveolar
damag
andor
boop
initi
follow
postinflammatori
chang
atelectasi
ongo
alveol
parenchym
fibrosi
later
cours
diseas
result
similar
longterm
followup
studi
beij
report
sar
survivor
patient
impair
dlco
wherea
exhibit
radiograph
evid
lung
fibrot
chang
year
sever
studi
ard
survivor
shown
pulmonari
function
gener
return
normal
near
normal
month
dlco
may
remain
abnorm
patient
year
recoveri
decreas
trend
va
discord
tlc
observ
studi
suggest
might
maldistribut
inert
ga
singlebreath
dlco
maneuv
set
occult
small
airway
obstruct
patient
although
expiratori
hrct
perform
adult
patient
pediatr
studi
asymptomat
children
month
diagnosi
sar
show
patient
pulmonari
abnorm
wherea
patient
evid
air
trap
expiratori
hrct
selfpac
perform
evalu
global
integr
respons
exercis
although
provid
specif
inform
function
individu
organ
system
although
show
consider
improv
month
markedli
reduc
age
group
compar
normal
control
subject
previou
studi
shown
substanti
lower
among
ard
survivor
control
subject
year
mechan
ventil
wherea
absenc
system
steroid
treatment
absenc
ill
acquir
icu
stay
rapid
resolut
lung
injuri
import
factor
associ
longer
month
respect
control
known
effect
age
gender
analysi
shown
percentag
predict
fvc
posit
independ
factor
associ
higher
month
wherea
percentag
predict
fvc
percentag
predict
dlco
posit
independ
predictor
month
given
rel
wellpreserv
lung
function
major
sar
survivor
poor
perform
age
group
could
due
addit
factor
muscl
wast
myopathi
possibl
cardiac
diastol
dysfunct
lau
et
al
note
muscl
strength
endur
impair
proxim
distal
muscl
among
survivor
sar
cohort
month
ill
onset
eighteen
sar
survivor
singapor
reduc
exercis
capac
month
hospit
discharg
could
account
impair
pulmonari
function
result
suggest
inabl
exercis
recov
sar
patient
primarili
due
extrapulmonari
caus
physic
decondit
possibl
steroid
myopathi
addit
sar
survivor
complain
among
sar
survivor
month
ill
onset
comparison
hk
norm
data
stratifi
differ
age
group
vertic
axi
repres
domain
score
mean
sd
minimum
maximum
wherea
horizont
axi
defin
age
group
year
base
studi
lam
et
al
normal
subject
normal
subject
age
group
year
year
respect
sar
survivor
sar
survivor
requir
icu
support
age
group
year
year
wherea
sar
survivor
sar
survivor
requir
icu
support
age
group
respect
signific
p
signific
p
signific
p
mth
month
degre
largejoint
pain
although
patient
includ
patient
current
studi
sar
survivor
cluster
hospit
evid
osteonecrosi
long
bone
mri
conduct
median
month
hospit
admiss
sever
possibl
caus
muscl
weak
among
sar
survivor
patient
complain
myalgia
elev
creatinin
kinas
suggest
viralinduc
myositi
initi
present
patient
requir
bed
rest
hospit
averag
week
long
period
bed
rest
could
lead
muscl
wast
decondit
wherea
use
system
corticosteroid
therapi
suppress
immunemedi
lung
injuri
could
contribut
myopathi
steroid
myopathi
report
patient
administ
highdos
steroid
acut
lung
transplant
reject
statu
asthmaticu
critic
illnessassoci
polyneuropathi
myopathi
also
observ
sar
survivor
small
proport
sar
patient
evid
respiratori
muscl
weak
inspiratori
muscl
weak
may
caus
atelectasi
wherea
expiratori
muscl
abdomin
intercost
muscl
weak
may
lead
air
trap
addit
signific
impair
health
statu
domain
among
patient
month
signific
posit
correl
lung
function
paramet
vc
fvc
fev
dlco
domain
pf
rp
gh
sf
also
signific
posit
correl
domain
except
mh
result
surpris
addit
physic
impair
long
period
isol
extrem
uncertainti
sar
ill
creat
enorm
psycholog
stress
mood
disturb
addit
steroid
toxic
person
vulner
psychosoci
stressor
might
jointli
contribut
develop
psychosi
patient
studi
acut
lung
injuri
ard
survivor
unrel
sar
report
impair
health
statu
year
recoveri
wherea
pulmonari
function
abnorm
especi
dlco
correl
domain
twentyseven
patient
studi
still
abnorm
radiograph
score
month
although
serial
cxr
show
signific
improv
posit
correl
extent
residu
radiograph
abnorm
cumul
steroid
dosag
use
sar
expect
former
indic
treatment
protocol
system
steroid
outbreak
neg
correl
residu
radiograph
abnorm
lung
volum
paramet
tlc
paramet
surfac
area
ga
exchang
dlco
reflect
physiolog
effect
parenchym
inflamm
fibrosi
patient
sever
diseas
reflect
higher
peak
ldh
level
requir
icu
support
acut
ill
residu
opac
cxr
month
addit
extens
pulmonari
injuri
fibrosi
reflect
significantli
lower
lung
volum
paramet
tlc
dlco
month
treat
gener
ward
howev
signific
differ
hrqol
two
group
month
addit
differ
function
paramet
icu
patient
receiv
receiv
mechan
ventil
herridg
et
al
report
ard
survivor
minor
abnorm
cxr
year
sever
limit
studi
firstli
among
normal
control
subject
subject
subject
age
group
year
year
wherea
subject
subject
sar
survivor
age
categori
respect
see
tabl
expans
abbrevi
p
p
p
perform
cardiopulmonari
exercis
test
cpet
mani
patient
complain
gener
muscl
weak
initi
followup
cpet
would
also
laborintens
larg
cohort
sar
survivor
nevertheless
reduc
pulmonari
ga
exchang
detect
cpet
survivor
sar
month
normal
dlco
secondli
survivor
cohort
complet
serial
assess
month
result
might
repres
entir
cohort
thirdli
assess
respiratori
muscl
strength
mouth
pressur
low
pemax
valu
alway
indic
expiratori
muscl
weak
might
result
technic
difficulti
mouth
leakag
lastli
could
measur
effect
extrapulmonari
factor
muscl
decondit
steroid
viralinduc
myopathi
cardiac
diastol
dysfunct
critic
ill
polyneuropathi
andor
myopathi
poor
perform
difficult
determin
contribut
psycholog
motiv
factor
mani
patient
seek
compens
occupationrel
sar
summari
studi
shown
signific
impair
dlco
sar
survivor
wherea
exercis
capac
health
statu
remark
lower
gener
popul
month
ill
onset
function
disabl
appear
proport
degre
lung
function
impair
may
due
addit
factor
muscl
decondit
steroidrel
musculoskelet
complic
critic
illnessrel
neuropathymyopathi
psycholog
factor
followup
need
assess
deficit
persist
